Search results
Results from the WOW.Com Content Network
The New England Journal of Medicine published two editorials in 2003 expressing concern about off-label uses of HGH and the proliferation of advertisements for "HGH-Releasing" dietary supplements, and emphasized that there is no evidence that use of HGH in healthy adults or in geriatric patients is safe and effective – and especially emphasized that risks of long-term HGH treatment are unknown.
Controversies regarding the use of human growth hormone (HGH) as treatment method have centered on the claims, products, and businesses related to the use of growth hormone as an anti-aging therapy. Most of these controversies fall into two categories: [ citation needed ]
The goal of nocturnal penile tumescence testing is to determine whether one can experience an erection while sleeping after reporting that they are unable to experience an erection while awake. On average, one has 3–5 episodes of NPT each night, and each episode lasts 30–60 minutes, although the duration is reduced with advanced age. [16]
Late-night alcohol has a sedative effect because it disrupts the brain’s natural stages of sleep. And that affects the brain’s ability to support better health and memory .
Off-label prescription of HGH is controversial and may be illegal. [55] Claims for GH as an anti-aging treatment date back to 1990 when the New England Journal of Medicine published a study wherein GH was used to treat 12 men over 60. [56]
Pelvic Floor Dysfunction in Men: Causes, Symptoms, and Treatment This article was reviewed by Martin Miner, MD. Although we don’t pay much attention to our pelvic floor muscles, they make ...
Many treatments for prediabetes can prevent the condition from developing in the first place. Prediabetes preventative measures include: Keeping your weight within a healthy range
Laron syndrome (LS), also known as growth hormone insensitivity or growth hormone receptor deficiency (GHRD), is an autosomal recessive disorder characterized by a lack of insulin-like growth factor 1 (IGF-1; somatomedin-C) production in response to growth hormone (GH; hGH; somatotropin). [6]